NCT04570670View on ClinicalTrials.gov

Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

February 17, 2017

Study Completion Date

February 17, 2017

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DRUG

monomethyl fumarate 190 mg

DRUG

dimethyl fumarate 240 mg

Sponsors
All Listed Sponsors
lead

Banner Life Sciences LLC

INDUSTRY